Oak Harvest Investment Services’s West Pharmaceutical WST Stock Holding History

Oak Harvest Investment Services’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.26M	Buy	+3,500	New	+$1.07M	0.12%	103

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Oak Harvest Investment Services's WST Position: Q2 2026 in Review

Oak Harvest Investment Services opened a new position in West Pharmaceutical (WST) in Q2 2026: 3,500 shares worth $1.26M. The stake represents 0.12% of the portfolio and ranks #103 among its holdings.

831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Oak Harvest Investment Services held 3,500 shares of West Pharmaceutical worth $1.26M as of Q2 2026.
West Pharmaceutical was a new Oak Harvest Investment Services position in Q2 2026.
West Pharmaceutical made up 0.12% of Oak Harvest Investment Services's portfolio in Q2 2026, its #103 holding.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Oak Harvest Investment Services's 13F filing for Q2 2026, filed 27 Jul 2026.